Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Gilead Sciences Inc (GILD)

Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 123,146,624
  • Shares Outstanding, K 1,245,163
  • Annual Sales, $ 28,754 M
  • Annual Income, $ 480,000 K
  • EBIT $ 8,221 M
  • EBITDA $ 10,988 M
  • 60-Month Beta 0.26
  • Price/Sales 4.24
  • Price/Cash Flow 14.25
  • Price/Book 6.39

Options Overview Details

View History
  • Implied Volatility 35.03% ( +6.09%)
  • Historical Volatility 32.51%
  • IV Percentile 95%
  • IV Rank 53.33%
  • IV High 49.97% on 04/08/25
  • IV Low 17.95% on 11/07/24
  • Put/Call Vol Ratio 1.08
  • Today's Volume 21,064
  • Volume Avg (30-Day) 10,672
  • Put/Call OI Ratio 1.14
  • Today's Open Interest 260,413
  • Open Int (30-Day) 243,231

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 28 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate 1.99
  • Number of Estimates 8
  • High Estimate 2.25
  • Low Estimate 1.90
  • Prior Year 2.01
  • Growth Rate Est. (year over year) -1.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
93.37 +5.13%
on 04/25/25
107.56 -8.74%
on 04/24/25
-5.03 (-4.87%)
since 04/08/25
3-Month
93.37 +5.13%
on 04/25/25
119.96 -18.17%
on 03/10/25
+2.12 (+2.21%)
since 02/07/25
52-Week
62.07 +58.14%
on 05/31/24
119.96 -18.17%
on 03/10/25
+33.24 (+51.20%)
since 05/08/24

Most Recent Stories

More News
Stocks See Support as US-UK Trade Deal Bolsters Trade Optimism

The S&P 500 Index ($SPX ) (SPY ) today is up +0.17%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.24%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.34%. June E-mini S&P futures (ESM25...

MSTR : 414.38 (+5.58%)
MPC : 149.97 (+3.65%)
APP : 339.51 (+11.88%)
TAP : 54.26 (-4.54%)
ADI : 202.78 (+1.46%)
SLB : 34.32 (+2.45%)
AMGN : 272.05 (-1.37%)
COIN : 206.50 (+5.06%)
OXY : 41.44 (+6.23%)
FANG : 136.18 (+5.10%)
AMD : 101.70 (+1.34%)
SPY : 565.06 (+0.70%)
Stocks Rally on UK Trade Deal and Chip Rule Change

The S&P 500 Index ($SPX ) (SPY ) today is up +0.57%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.53%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.79%. June E-mini S&P futures (ESM25...

MSTR : 414.38 (+5.58%)
GOOGL : 154.28 (+1.92%)
APP : 339.51 (+11.88%)
TAP : 54.26 (-4.54%)
ADI : 202.78 (+1.46%)
MRK : 77.65 (-1.86%)
G : 42.04 (-15.16%)
AXON : 686.83 (+14.13%)
$IUXX : 20,063.57 (+0.98%)
AMGN : 272.05 (-1.37%)
COIN : 206.50 (+5.06%)
PFE : 22.97 (+0.79%)
Stocks Retreat on Concerns About Economic Damage from Tariffs

The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.77%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.95%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.88%. June E-mini...

AMAT : 156.00 (+0.12%)
ADI : 202.78 (+1.46%)
MRK : 77.65 (-1.86%)
FN : 208.10 (-0.86%)
ADM : 47.70 (-0.38%)
$IUXX : 20,063.57 (+0.98%)
DASH : 182.96 (+3.37%)
PFE : 22.97 (+0.79%)
CLX : 137.81 (+0.97%)
ZNM25 : 110-270 (+0.04%)
ESM25 : 5,685.50 (+0.02%)
GFS : 35.94 (+1.84%)
What Are Wall Street Analysts' Target Price for Gilead Sciences Stock?

Gilead Sciences has considerably outpaced the broader market over the past year, and Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

$SPX : 5,663.94 (+0.58%)
PJP : 79.40 (-0.16%)
GILD : 98.16 (-0.75%)
MFG : 4.97 (+1.22%)
1 Profitable Stock on Our Watchlist and 2 to Turn Down

1 Profitable Stock on Our Watchlist and 2 to Turn Down

VEEV : 239.53 (+0.51%)
CTOS : 4.27 (+3.64%)
GILD : 98.16 (-0.75%)
3 Biotech Giants Gaining From U.S. Sales and Policy Shifts

The significant domestic revenue base of select US biotech companies offers stability potential for investors navigating global trade complexities.

GILD : 98.16 (-0.75%)
ABBV : 185.58 (-1.33%)
AMGN : 272.05 (-1.37%)
Should You Buy, Sell or Hold GILD Stock Post Q1 Earnings Miss?

Last week, biotech bigwig Gilead Sciences, Inc. GILD reported lower-than-expected first-quarter 2025 results. Adjusted earnings per share (EPS) of $1.81 missed the Zacks Consensus Estimate by a penny....

MRK : 77.65 (-1.86%)
GILD : 98.16 (-0.75%)
GSK : 36.87 (-0.81%)
These 3 Funds Offer Sky-High Yields of 15% or More and Trade at a Discount

My definition of a high yield is any yield at least twice the level of the S&P 500 's yield. The threshold is currently around 2.56%. An ultra-high yield, in my view, is one that's four times higher than...

BLK : 928.64 (+0.90%)
GOOGL : 154.28 (+1.92%)
NVDA : 117.37 (+0.26%)
GOOG : 155.75 (+1.93%)
MMC : 228.43 (+0.23%)
HQL : 12.02 (-0.91%)
SPOT : 655.26 (-0.28%)
BSTZ : 18.23 (+0.50%)
VRTX : 429.60 (-1.20%)
ALNY : 258.35 (-6.58%)
BCAT : 14.76 (+0.20%)
AMGN : 272.05 (-1.37%)
CIBC introduces additional U.S. Canadian Depositary Receipts ("CDRs")

/CNW/ - Today CIBC announced 15 new U.S. Canadian Depositary Receipts ("CDRs"), now listed on Cboe Canada. Introduced to investors over three years ago, CIBC...

AZO : 3,674.73 (-1.89%)
MS : 121.88 (+2.33%)
SCHW : 84.37 (+0.43%)
PEP : 131.43 (-0.37%)
GILD : 98.16 (-0.75%)
United Therapeutics (UTHR) To Report Earnings Tomorrow: Here Is What To Expect

United Therapeutics (UTHR) To Report Earnings Tomorrow: Here Is What To Expect

ABBV : 185.58 (-1.33%)
GILD : 98.16 (-0.75%)
UTHR : 308.00 (+0.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Gilead Sciences is a pioneer in developing drugs for the treatment of human immunodeficiency virus, liver diseases, hematology/oncology diseases and inflammation/respiratory diseases. The company has a strong HIV franchise with key HIV/AIDS therapies like tenofovir alafenamide based products - Genvoya,...

See More

Key Turning Points

3rd Resistance Point 102.45
2nd Resistance Point 100.44
1st Resistance Point 99.30
Last Price 98.16
1st Support Level 96.16
2nd Support Level 94.15
3rd Support Level 93.01

See More

52-Week High 119.96
Last Price 98.16
Fibonacci 61.8% 97.85
Fibonacci 50% 91.01
Fibonacci 38.2% 84.18
52-Week Low 62.07

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar